Preclinical evidence for combining the 5-HT
Animals
Benzazepines
/ metabolism
Conditioning, Operant
/ drug effects
Drug Combinations
Drug-Seeking Behavior
/ drug effects
Feeding Behavior
/ drug effects
Impulsive Behavior
/ drug effects
Male
Rats, Long-Evans
Reinforcement, Psychology
Serotonin 5-HT2 Receptor Agonists
/ pharmacology
Smoking Cessation Agents
/ metabolism
Tobacco Use Disorder
/ drug therapy
Varenicline
/ metabolism
impulsive action
lorcaserin
nicotine self-administration
reinstatement
varenicline
Journal
Addiction biology
ISSN: 1369-1600
Titre abrégé: Addict Biol
Pays: United States
ID NLM: 9604935
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
02
08
2017
revised:
15
12
2017
accepted:
24
12
2017
pubmed:
3
3
2018
medline:
19
5
2020
entrez:
3
3
2018
Statut:
ppublish
Résumé
Varenicline, a nicotinic acetylcholine receptor partial agonist, is used to treat nicotine dependence. Lorcaserin, a 5-HT
Substances chimiques
Benzazepines
0
Drug Combinations
0
Serotonin 5-HT2 Receptor Agonists
0
Smoking Cessation Agents
0
lorcaserin
637E494O0Z
Varenicline
W6HS99O8ZO
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
376-387Subventions
Organisme : InterVivo Solutions Inc
Pays : International
Organisme : CIHR
ID : MOP-13628
Pays : Canada
Informations de copyright
© 2018 Society for the Study of Addiction.